SCHEMBL31301535

SCHEMBL31301535

CN(C(=O)c1cc(-c2ccc(Cl)cc2)ccn1)c1ccc(Cl)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 1/20 0.51
GPBAR1 Q8TDU6 10/20 0.48
PIK3CD O00329 1/20 0.47
PIK3CB P42338 1/20 0.47
PI4KA P42356 1/20 0.47
PIK3CG P48736 1/20 0.47
PIK3C3 Q8NEB9 1/20 0.47
MAP4K4 O95819 1/20 0.46
ALDH1A1 P00352 1/20 0.46
MAPT P10636 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
KMO O15229 1/20 0.44
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
CHEK2 O96017 1/20 0.42
MALT1 Q9UDY8 1/20 0.40
PSEN1 P49768 1/20 0.40
PSEN2 P49810 1/20 0.40
APH1B Q8WW43 1/20 0.40
NCSTN Q92542 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31301274 0.95 GPBAR1 (0.53) CNR2GPBAR1PIK3CDPIK3CBPI4KA
SCHEMBL31301452 0.95 GPBAR1 (0.53) CNR2GPBAR1PIK3CDPIK3CBPI4KA
SCHEMBL31301389 0.90 CNR2 (0.45) CNR2GPBAR1PIK3CDPIK3CBPI4KA
SCHEMBL31301399 0.84 ALDH1A1 (0.49) CNR2GPBAR1PIK3CDPIK3CBPI4KA
SCHEMBL31301484 0.81 CNR2 (0.50) CNR2GPBAR1MAP4K4ALDH1A1MAPT
SCHEMBL31301327 0.80 MAP4K4 (0.48) GPBAR1PIK3CDPIK3CBPI4KAPIK3CG
SCHEMBL31301410 0.80 KMO (0.62) GPBAR1PIK3CDPIK3CBPI4KAPIK3CG
SCHEMBL14883216 0.79 GAA (0.52) GPBAR1ALDH1A1MAPTL3MBTL1MEN1
SCHEMBL24405063 0.78 MAP4K4 (0.53) CNR2MAP4K4ALDH1A1MAPTL3MBTL1
SCHEMBL31301563 0.77 MAP4K4 (0.50) GPBAR1PIK3CDPIK3CBPI4KAPIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4727549-A2 PLASMODIUM FALCIPARUM BLOOD STAGE INHIBITORS University of Georgia Research Foundation, Inc. (US) 2026-04-22 EP disclosed
US-20260097046-A1 PLASMODIUM FALCIPARUM BLOOD STAGE INHIBITORS UNIV GEORGIA (US) 2026-04-09 US disclosed
WO-2024258900-A2 PLASMODIUM FALCIPARUM BLOOD STAGE INHIBITORS UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 2024-12-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260097046-A1 PLASMODIUM FALCIPARUM BLOOD STAGE INHIBITORS SUB1, PFN1, HCCS CNR2 1803/4885GPBAR1 803/4885PIK3CD 1087/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.